HD
Therapeutic Areas
CPTx Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Dual CAR (CD19/CD20) Program | Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| Dual CAR (CD19/CD20) Program | Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Pre-clinical |